February 5, 2015
February 5, 2015 —
Between 5 and 8 million children in the United States have nonalcoholic fatty liver disease (NAFLD), yet most cases go undiagnosed. To help address this issue, researchers at UC San Diego School of Medicine have developed a new magnetic resonance imaging (MRI)-based technique to help clinicians and researchers better detect…
May 2, 2017
May 2, 2017 —
Nonalcoholic fatty liver disease (NAFLD) — a condition that can lead to liver cirrhosis and cancer — isn’t typically detected until well advanced. Even then, diagnosis requires a biopsy. To more easily detect NAFLD, UC San Diego School of Medicine researchers and their collaborators report that the microbial makeup of…
January 12, 2021
January 12, 2021 —
Researchers at UC San Diego School of Medicine, in collaboration with Dutch scientists, have found that certain metabolites — small molecules produced by the process of metabolism — may be predictive indicators for persons at risk for recurrent major depressive disorder.
May 21, 2024
May 21, 2024 —
A $21M gift from Aiiso Yufeng Li (Jeff) and his wife, DongDong Li (Doreen), honors unique efforts at UC San Diego to link chemical and nano engineering more strongly. In recognition of this gift, the department will be named the Aiiso Yufeng Li Family Department of Chemical and Nano Engineering.
February 24, 2014
February 24, 2014 —
A study led by physicians at the University of California, San Diego School of Medicine and Rady Children’s Hospital-San Diego looked at intensification of initial therapy for all children with Kawasaki Didease in order to prevent IVIG-resistance and associated coronary artery abnormalities by assessing the addition of the medication infliximab…
February 8, 2023
February 8, 2023 —
Toddlers’ level of attention to “motherese” speech can be used as a biomarker for autism spectrum disorder (ASD). UC San Diego scientists developed a new eye-tracking test to measure it, which can accurately identify toddlers with a subtype of ASD.
July 19, 2022
July 19, 2022 —
With a $45 million grant from the NIH, UC San Diego researchers and collaborators will launch a nationwide clinical trial to further investigate the therapeutic potential of benfotiamine, a synthetic version of thiamine (B1), as a treatment for Alzheimer’s disease.
December 10, 2015
December 10, 2015 —
When someone experiences a major stroke, almost two million nerve cells in the brain die each minute, emphasizing the need for rapid treatment. Stroke patients who receive life-saving interventions more quickly have a higher chance of recovery. A recent data analysis showed the Comprehensive Stroke Center at UC San Diego…
March 9, 2015
March 9, 2015 —
In a study published in the current online issue of JAMA Psychiatry, an international team of scientists, led by researchers at the University of California, San Diego School of Medicine, report finding a highly accurate blood-based measure that could lead to development of a clinical test for autism spectrum disorder…
October 24, 2012
October 24, 2012 —
When members of UC San Diego’s Center of Interdisciplinary Science for Art, Architecture and Archaeology (CISA3) participated in a program for over 100 graduate and undergraduate students and alumni from various disciplines under the aegis of the university’s International Affairs Group (IAG), both sides came away pledging to continue the…